• National consensus on the management of patients with cervical intraepithelial neoplasia caused by papillomavirus infection
To content

National consensus on the management of patients with cervical intraepithelial neoplasia caused by papillomavirus infection

HEALTH OF WOMAN. 2017.7(123):16–24

National consensus on the management of patients with cervical intraepithelial neoplasia caused by papillomavirus infection

REFERENCES

1. Human papillomavirus infection. Introduction of HPV vaccines in European Union countries – an update. 2012.

2. Bruni L, Diaz M, Castellsague X. 2010, December 15. Cervical Human Papillomavirus Prevalence in 5 Continents: Meta-Analysis of 1 Million Women with Normal Cytological Findings. J. Infect. Dis. 202:1790. https://doi.org/10.1086/657321; PMid:21067372

3. Cutts FT, Franceschi S, Goldie S. 2009. Human papillomavirus and HPV vaccines: a review. Bulletin of theWorld Health Organization.

4. Atkinson W, Wolfe S, Hamborsky J. 2012. Human Papillomavirus. Epidemiology and Prevention of Vaccine Preventable Diseases. The Pink Book: Course Textbook. – 12th Edition Second Printing.

5. Atkinson W, Wolfe S, Hamborsky J. 2012. Human Papillomavirus. Epidemiology and Prevention of Vaccine Preventable Diseases. The Pink Book: Course Textbook. 12th Edition Second Printing.

6. Herbert A, Bergeron C, Wiener H et al. 2007. European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology. Cytopathology 18:213–219. https://doi.org/10.1111/j.1365-2303.2007.00469.x; PMid:17635161

7. Arbyn M, Anttila A, Jordan J et al. 2008. European guidelines for quality assurance in cervical cancer screening Second Edition.

8. Comprehensive Cervical Cancer Control. A guide to essential practice, 2010, World Health Organization, www://whqlibdoc.who. int/publications/2006/9241547006_eng.pdfua=1.

9. European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid-based cytology. 2007.

10. Berzolla CE. 2007, Nov. Dysplasia and malignancy in endocervical polyps. J Womens Health (Larchmt). 16(9):1317–1321. https://doi.org/10.1089/jwh.2007.0408; PMid:18001188

11. Dzhei Naomi, Mostsitski Anna-Barbara. 2010. Papilomavirusna infektsiia u zhinok. Zhinka i zdorovia 2:196.

12. Patologiya sheyki i tela matki: rukovodstvo dlya vrachey akusherov-ginekologov, onkologov, tsitologov, gistologov, prepodavateley i studentov med. in-tov. Pod red. EV Kohanevich. Nezhin: Gidromaks. 2009:350.

13. Timushsh E, Adams K. 2009. Sheyka matki. Tsitologicheskiy atlas. Per. s angl. pod red. NI Kondrikova. M, Prakticheskaya meditsina:251.

14. Danilova NV, Andreeva YuYu, Zavalishina LE, Kekeeva TV, Malkov PG, Frank GA. 2012. Opuholi sheyki matki. Morfologicheskaya diagnostika i genetika: Rukovodstvo dlya vrachey. Pod red. YuYu Andreevoy, GA Franka. M, Prakticheskaya meditsina:116.

15. Voloshina NN, Voloshin NA. 2010. Skrining i profilaktika raka sheyki matki. Zaporozhe: Pechatnyiy mir:155.

16. Voytenko GN, Kohanov IV. 2016. Farmakoekonomicheskoe obosnovanie primeneniya preparata proteflazid v terapii papillomavirusnoy infektsii. «Retsept». 19;3.

17. Zaporozhan VN, Marichereda VG, Dimcheva LI. 2014. Application of flavonivyh glycosides papilomavirusnoy therapy of genital infection in women. Journal of Health Sciences. 4(12):93–104. ISSN 1429-9623 / 2300-665X.

18. Ventskivskyi BM, Poladych IV, Bila VV, Kostenko OIu, Kazydub KS. 2015. Osoblyvosti perebihu vahitnosti ta polohiv u zhinok z bahatopliddiam. Medytsyna transportu Ukrainy 3–4:8–15.

19. Ventskovsky В, Grynevych O, MD, Mikhailov V, Lesnikova M, Yaschenko L, Broun T. 2016, January-June. Proteflazid® in the treatment and prevention of human herpesvirus infection in pregnant women: a meta-analysis of clinical trials results. American Journal of Science and Technologies 1(21):983–1002.

20. Hodlevska NA, Starovir AV. 2012. Efektyvnist systemnoho ta mistsevoho zastosuvannia preparatu Proteflazid u likuvanni patolohii shyiky matky, sprychynenoi papilomavirusnoiu infektsiieiu. Zdorove zhenshchynы 3(69):80–83.

21. Hodlevska NA, Starovir AV. 2017. Klinichna efektyvnist mistsevoho zastosuvannia vahinalnykh supozytoriiv Proteflazid® u likuvanni tservikalnoi intraepitelialnoi neoplazii lehkoho ta pomirnoho stupeniv, zumovlenoi virusom papilomy liudyny. Zdorove zhenshchynу 2(118):55–60.